Clinical Trials on Propofol Plasma Concentration in Japan
Total 145 results
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration Change of QuetiapineJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
Fresenius Kabi JapanCompletedPlasma Volume Substitution (Hypovolemia) Including Massive HemorrhageJapan
-
EPS CorporationCompletedLiver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal CancerJapan
-
TakedaCompleted
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Completed
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
CelgeneCompleted
-
Bristol-Myers SquibbCompleted
-
GlaxoSmithKlineActive, not recruiting
-
Eli Lilly and CompanyCompleted
-
SymBio PharmaceuticalsTerminated
-
Janssen Pharmaceutical K.K.Completed
-
Novartis PharmaceuticalsTerminatedNeoplasms, HaematologicJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.TerminatedMultiple MyelomaJapan
-
Bristol-Myers SquibbCompleted
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan
-
PfizerActive, not recruitingLymphoma | Multiple MyelomaJapan
-
Cutera Inc.CompletedMelasma | LentiginesChina, Japan
-
CelgeneCompleted
-
CelgeneCompletedMyelodysplastic Syndromes | Multiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Bristol-Myers SquibbAbbVieNo longer available
-
Genzyme, a Sanofi CompanyCompleted
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMultiple Myeloma (MM)Japan
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)Japan
-
CelgeneCompleted
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
Celgene CorporationCompleted
-
Novartis PharmaceuticalsCompleted
-
Janssen Pharmaceutical K.K.CompletedWaldenstrom MacroglobulinemiaJapan
-
CelgeneCompletedMultiple MyelomaUnited States, Japan
-
CelgeneCompleted
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
AbbVieActive, not recruiting
-
SymBio PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Active, not recruitingHematologic MalignanciesJapan
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
PfizerRecruitingMultiple MyelomaCanada, France, Japan, Australia, United States
-
CelgeneCompleted